Prevention of hepatic fibrosis in nonobese diabetic mice: A critical role for interferon-γ

Liver International

Volumn 26, Issue 8, 2006, Pages 1006-1014

  Mukai, Tsuyoshi ^a   Nagaki, Masahito ^a   Imose, Motoaki ^a   Kimura, Kiminori ^a   Satake, Shinichi ^a   Takai, Shinji ^a   Moriwaki, Hisataka ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Cytokines; Inflammation; T cell

Indexed keywords

AMINOTRANSFERASE; CYTOKINE; DIMETHYLNITROSAMINE; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; HYDROXYPROLINE; MESSENGER RNA; NEUTRALIZING ANTIBODY;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FIBROGENESIS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; INTERFERON INDUCTION; LETHALITY; LIVER CELL; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER INJURY; LIVER NECROSIS; MOUSE; MOUSE STRAIN; NICK END LABELING; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RISK REDUCTION; SURVIVAL RATE; T LYMPHOCYTE;

ANIMALS; DIMETHYLNITROSAMINE; FEMALE; INTERFERON TYPE II; INTERFERON-GAMMA; LIVER CIRRHOSIS; MICE; MICE, INBRED ICR; MICE, INBRED NOD;

EID: 33748303039     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2006.01322.x     Document Type: Article

References (37)

1. Canbay A, Friedman S, Gregory G J. Apoptosis: The nexus of liver injury and fibrosis. Hepatology 2004; 39: 273-8.
2. Rojkind M, Giambrone M A, Biempica L. Collagen types in normal and cirrhotic liver. Gastroenterology 1979; 76: 710-19.
3. Friedman S L. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993; 328: 1828-35.
4. Pinzani M. Hepatic stellate (ITO) cells: Expanding roles for a liver-specific pericyte. J Hepatol 1995; 22: 700-6.
5. Matsuoka M, Pham N T, Tsukamoto H. Differential effects of interleukin-1α, tumor necrosis factor α, and transforming growth factor β1 on cell proliferation and collagen formation by cultured fat-storing cells. Liver 1989; 9: 71-8.
6. Nakatsukasa H, Nagy P, Evarts R P, et al. Cellular distribution of transforming growth factor-β1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest 1990; 85: 1833-43.
7. Czaja M J, Weiner F R, Flanders K C, et al. In vitro and vivo association of transforming growth factor-β1 with hepatic fibrosis. J Cell Biol 1989; 108: 2477-82.
8. Czaja M J, Weiner, F R Takahashi S, et al. γ-interferon treatment inhibits collagen deposition in murine schistosomiasis. Hepatology 1989; 10: 795-800.
9. Inagaki Y, Nemoto T, Kushida M, et al. Interferon alfa down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice. Hepatology 2003; 38: 890-9.
10. Vaillant B, Chiaramonte M G, Cheever A W, et al. Regulation of hepatic fibrosis and extracellular matrix genes by the Th response: New insight into the role of tissue inhibitors of matrix metalloproteinases. J Immunol 2001; 167: 7017-26.
11. Wicker L S, Todd J A, Peterson L B. Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 1995; 13: 179-200 (Review).
12. Abbas A K, Murphy K M, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383: 787-93 (Review).
13. Honda H, Ikejima K, Hirose M, et al. Leptin is required fibrogenic responses induced by thioacetamide in the murine liver. Hepatology 2002; 36: 12-21.
14. Ingalls A M, Dickie M M, Snell G D. Obese, a new mutation in the house mouse. J Heredity 1950; 41: 317-8.
15. Neuschwander B A, Caldwell S H. Nonalcoholic Steatohepatitis; Summary of an AASLD single topic conference. Hepatology 2003; 37: 1202-19 (Review).
16. Leiter E H, Prochazka M, Coleman D L. The non-obese diabetic (NOD) mouse. Am J Pathol 1987; 128: 380-3.
17. Yoshida K, Kikutani H. Genetic and immunological basis of autoimmune diabetes in the NOD mice. Rev Immunogenet 2000; 2(1): 140-6 (Review).
18. Makino S, Kunimoto K, Muraoka Y, et al. Breeding of a non-obese, diabetic strain of mice. Exp Anim 1980; 29: 1-13.
19. Kikutani H, Makino S. The murine autoimmune diabetes model: NOD and related strains. Adv Immunol 1992; 51: 285-322.
20. Rabinovitch A. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation? Diabetes 1994; 43: 613-21.
21. Rabinovitch A, Suarez-Pinzon W L, Sorensen O, et al. IFN-γ gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetes mice. J Immunol 1995; 154: 4874-82.
22. Cameron M J, Arreaza G A, Zucker P, et al. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetes mice by potentiation of regulatory T helper-2 cell function. J Immunol 1997; 61: 507-16.
23. Bao M, Yang Y, Jun H S, Yoon J W. Molecular mechanisms for gender differences in susceptibility to T cell-mediated autoimmune diabetes in nonobese diabetic mouse. J Immunol 2002; 168: 5369-75.
24. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-9.
25. Imose M, Nagaki M, Kimura K, et al. Leflunomide protects from T-cell-mediated liver injury in mice through inhibition of nuclear factor kappaB. Hepatology 2004; 40: 1160-9.
26. Kimura K, Nagaki M, Takai S, et al. Pivotal role of nuclear factor κB signaling in anti-CD40-induced liver injury in mice. Hepatology 2004; 40: 1180-9.
27. Bahjat F R, Dharnidharka V R, Fukuzawa K, et al. Reduced susceptibility of nonobese diabetic mice to TNF-α and d-galactosamine-mediated hepatocellular apoptosis and lethality. J Immunol 2000; 165: 6559-67.
28. Boehm U, Klamp T, Groot M, Howard J C. Cellular responses to interferon-γ. Annu Rev Immunol 1997; 15: 749-95.
29. King C, Sarvetnick N. Organ-specific autoimmunity. Curr Opin Immunol 1997; 9: 863-71.
30. Jimenez S A, Freundich B, Rosenbloom J. Selective inhibition of human diploid fibroblast collagen synthesis by interferons. J Clin Invest 1984; 74: 1112-6.
31. Granstein R D, Murphy G F, Margolis R J, et al. Gamma-interferon inhibits collagen synthesis in vivo in the mouse. J Clin Invest 1987; 79: 1254-8.
32. Raghu G, Brown K K, Bradford W Z, et al. Idiopathic pulmonary fibrosis study group. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 2004; 350: 125-33.
33. Shi Z, Wakil A E, Rockey D C. Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc Natl Acad Sci USA 1997; 94: 10663-8.
34. Chevillard C, Moukoko CE, Elwali NE, et al. IFN-γ polymorphisms (IFN-γ+2109 and IFN-γ+3810) are associated with severe hepatic fibrosis in human hepatic schistosomiasis (Schistosoma mansoni). J Immunol 2003; 171: 5596-601.
35. Booth M, Mwatha J K, Joseph S, et al. Periportal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-γ, high TNF-α, or low RANTES, depending on age and gender. J Immunol 2004; 172: 1295-303.
36. Baroni G S, D'ambrosio L, Curto P, et al. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology 1996; 23: 1189-99.
37. Saile B, Eisenbach C, Dudas J, et al. Interferon-gamma acts proapoptotic on hepatic stellate cells (HSC) and abrogates the antiapoptotic effect of interferon-alpha by an HSP70-dependant pathway. Eur J Cell Biol 2004; 83: 469-76.